Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 44 member 1 (SLC44A1), also known as choline transporter-like protein 1 (CTL1), is a membrane transporter responsible for the sodium-independent transmembrane uptake of choline and ethanolamine. It is expressed ubiquitously across human tissues—including plasma membranes and mitochondria—and is essential for metabolic pathways such as phosphatidylcholine, betaine, and acetylcholine synthesis. SLC44A1 function is critical for maintaining membrane lipid homeostasis, supporting the synthesis of neurotransmitters in neurons, and ensuring adequate choline supply during development, cell differentiation, H1 and rapid cell proliferation (e.g., in cancer). Inhibition of SLC44A1 with the compound hemicholinium-3 (HC-3) is used experimentally to block choline uptake. Genetic alterations—such as SLC44A1-PRKCA gene fusion in papillary glioneuronal tumor—and loss-of-function mutations have clinical consequence, linking SLC44A1 to roles in various diseases including cancers, neurodegenerative disorders, and metabolic or developmental syndromes[1][2][3][4].
Inhibition of choline uptake through competitive blockade of the transporter
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 44 member 1 (SLC44A1).